Correction to: A reactive oxygen species scoring system predicts cisplatin sensitivity and prognosis in ovarian cancer patients. Sun C, Guo E, Zhou B, Shan W, et al. BMC Cancer 2020;20:210.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Sun C, Guo E, Zhou B, Shan W, et al. Correction to: A reactive oxygen species scoring system predicts cisplatin sensitivity and prognosis in ovarian cancer patients. BMC Cancer 2020;20:210.
PMID: 32164614